These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 10762016)
1. Differential expression of genes by tumor cells of a low or a high malignancy phenotype: the case of murine and human Ly-6 proteins. Witz IP J Cell Biochem Suppl; 2000; 34():61-6. PubMed ID: 10762016 [TBL] [Abstract][Full Text] [Related]
2. A gain of novel tissue specificity in the human Ly-6 gene E48. Brakenhoff RH; van Dijk M; Rood-Knippels EM; Snow GB J Immunol; 1997 Nov; 159(10):4879-86. PubMed ID: 9366413 [TBL] [Abstract][Full Text] [Related]
3. Tumor-microenvironment interactions: the fucose-generating FX enzyme controls adhesive properties of colorectal cancer cells. Zipin A; Israeli-Amit M; Meshel T; Sagi-Assif O; Yron I; Lifshitz V; Bacharach E; Smorodinsky NI; Many A; Czernilofsky PA; Morton DL; Witz IP Cancer Res; 2004 Sep; 64(18):6571-8. PubMed ID: 15374970 [TBL] [Abstract][Full Text] [Related]
4. The GPI-linked Ly-6 antigen E48 regulates expression levels of the FX enzyme and of E-selectin ligands on head and neck squamous carcinoma cells. Eshel R; Zanin A; Sagi-Assif O; Meshel T; Smorodinsky NI; Dwir O; Alon R; Brakenhoff R; van Dongen G; Witz IP J Biol Chem; 2000 Apr; 275(17):12833-40. PubMed ID: 10777581 [TBL] [Abstract][Full Text] [Related]
5. Human Ly-6 antigen E48 (Ly-6D) regulates important interaction parameters between endothelial cells and head-and-neck squamous carcinoma cells. Eshel R; Zanin A; Kapon D; Sagi-Assif O; Brakenhoff R; van Dongen G; Witz IP Int J Cancer; 2002 Apr; 98(6):803-10. PubMed ID: 11948455 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients. Colnot DR; Nieuwenhuis EJ; Kuik DJ; Leemans CR; Dijkstra J; Snow GB; van Dongen GA; Brakenhoff RH Clin Cancer Res; 2004 Dec; 10(23):7827-33. PubMed ID: 15585614 [TBL] [Abstract][Full Text] [Related]
7. Differential proteome expression associated with urokinase plasminogen activator receptor (uPAR) suppression in malignant epithelial cancer. Saldanha RG; Xu N; Molloy MP; Veal DA; Baker MS J Proteome Res; 2008 Nov; 7(11):4792-806. PubMed ID: 18808175 [TBL] [Abstract][Full Text] [Related]
8. Differential expression of the murine Ly-6A/E antigen homolog of human squamous cell carcinoma antigen E48 during malignant transformation and tumor progression of squamous cell carcinoma line Pam 212. Kato T; Dong G; Loukinova E; Chen Z; Van Waes C Otolaryngol Head Neck Surg; 1998 Oct; 119(4):408-11. PubMed ID: 9782003 [TBL] [Abstract][Full Text] [Related]
9. Isolation and expression of an IFN-responsive Ly-6C chromosomal gene. Bothwell A; Pace PE; LeClair KP J Immunol; 1988 Apr; 140(8):2815-20. PubMed ID: 3356904 [TBL] [Abstract][Full Text] [Related]
10. The human E48 antigen, highly homologous to the murine Ly-6 antigen ThB, is a GPI-anchored molecule apparently involved in keratinocyte cell-cell adhesion. Brakenhoff RH; Gerretsen M; Knippels EM; van Dijk M; van Essen H; Weghuis DO; Sinke RJ; Snow GB; van Dongen GA J Cell Biol; 1995 Jun; 129(6):1677-89. PubMed ID: 7790363 [TBL] [Abstract][Full Text] [Related]
11. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer. Zhang H; Stephens LC; Kumar R Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771 [TBL] [Abstract][Full Text] [Related]
12. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling. Mamoune A; Kassis J; Kharait S; Kloeker S; Manos E; Jones DA; Wells A Exp Cell Res; 2004 Sep; 299(1):91-100. PubMed ID: 15302576 [TBL] [Abstract][Full Text] [Related]
13. Plasticity in urokinase-type plasminogen activator receptor (uPAR) display in colon cancer yields metastable subpopulations oscillating in cell surface uPAR density--implications in tumor progression. Yang L; Avila H; Wang H; Trevino J; Gallick GE; Kitadai Y; Sasaki T; Boyd DD Cancer Res; 2006 Aug; 66(16):7957-67. PubMed ID: 16912170 [TBL] [Abstract][Full Text] [Related]
14. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder. Bhuvarahamurthy V; Schroeder J; Denkert C; Kristiansen G; Schnorr D; Loening SA; Jung K; Staack A Oncol Rep; 2004 Oct; 12(4):909-13. PubMed ID: 15375521 [TBL] [Abstract][Full Text] [Related]
15. Expression of Ly-6, a marker for highly malignant murine tumor cells, is regulated by growth conditions and stress. Treister A; Sagi-Assif O; Meer M; Smorodinsky NI; Anavi R; Golan I; Meshel T; Kahana O; Eshel R; Katz BZ; Shevach E; Witz IP Int J Cancer; 1998 Jul; 77(2):306-13. PubMed ID: 9650569 [TBL] [Abstract][Full Text] [Related]
16. Variability in the expression of urokinase receptor (CD87) mutants on cells: relevance to cell adhesion. Kanse SM; Chavakis T; Kuo A; Bdeir K; Cines DB; Preissner KT Cell Biochem Funct; 2004; 22(4):257-64. PubMed ID: 15248186 [TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer. Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460 [TBL] [Abstract][Full Text] [Related]
18. Identification of genes involved in human urothelial cell-matrix interactions: implications for the progression pathways of malignant urothelium. Smith BA; Kennedy WJ; Harnden P; Selby PJ; Trejdosiewicz LK; Southgate J Cancer Res; 2001 Feb; 61(4):1678-85. PubMed ID: 11245483 [TBL] [Abstract][Full Text] [Related]
19. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors. Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003 [TBL] [Abstract][Full Text] [Related]
20. High level synthesis of recombinant soluble urokinase receptor (CD87) by ovarian cancer cells reduces intraperitoneal tumor growth and spread in nude mice. Lutz V; Reuning U; Krüger A; Luther T; von Steinburg SP; Graeff H; Schmitt M; Wilhelm OG; Magdolen V Biol Chem; 2001 May; 382(5):789-98. PubMed ID: 11517932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]